Amphastar Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
CTLTCatalent, Inc. -1.52%83.582.1%$219.42m
JAZZJazz Pharmaceuticals Plc -3.52%136.902.4%$157.00m
HZNPHorizon Therapeutics Plc -3.08%77.475.8%$147.78m
SAVACassava Sciences, Inc. -10.92%8.970.0%$144.98m
CORTCorcept Therapeutics, Inc. -2.67%17.515.5%$122.63m
VRXValeant Pharmaceuticals International, Inc. -4.01%16.5014.1%$97.09m
BHCBausch Health Cos., Inc. -3.96%16.510.0%$68.41m
AMRNAmarin Corp. Plc -4.08%4.001.5%$54.41m
MYOKMyoKardia, Inc. -7.89%125.781.8%$53.15m
ARGXargenx SE -3.39%241.290.0%$51.72m
SAGESAGE Therapeutics, Inc. -3.83%60.068.6%$44.66m
GWPHGW Pharmaceuticals Plc -1.42%98.766.2%$40.16m
AXSMAxsome Therapeutics, Inc. -1.87%80.121.9%$38.28m
MRNSMarinus Pharmaceuticals, Inc. -3.31%3.351.9%$37.41m
PRGOPerrigo Co. Plc -3.46%45.446.8%$34.66m

Company Profile

Amphastar Pharmaceuticals, Inc. engages in the development, manufacture, market, and sale of technically challenging and proprietary injectable, inhalation, and intranasal products. It operates through Finished Pharmaceutical Products, and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets and distributes enoxaparin, cortrosyn, amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment manufactures and distributes recombinant human insulin and porcine insulin. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.